| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | affects expression | ISO | RGD:1308091 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of E2F8 mRNA | CTD | PMID:19414516 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of E2F8 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | increases expression | ISO | RGD:1605946 | 6480464 | Estradiol results in increased expression of E2F8 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | increases expression | ISO | RGD:1605946 | 6480464 | Estradiol results in increased expression of E2F8 mRNA | CTD | PMID:19167446 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of E2F8 gene | CTD | PMID:21212295 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1605946 | 6480464 | Tetrachlorodibenzodioxin affects the expression of E2F8 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1605946 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of E2F8 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases methylation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased methylation of E2F8 gene | CTD | PMID:21212295 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1605946 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of E2F8 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of E2F8 mRNA | CTD | PMID:16214954 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of E2F8 mRNA | CTD | PMID:19812364 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of E2F8 mRNA | CTD | PMID:20713471 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of E2F8 mRNA | CTD | PMID:19191707 |
| 5-fluorouracil | affects expression | ISO | RGD:1605946 | 6480464 | Fluorouracil affects the expression of E2F8 mRNA | CTD | PMID:16584549 |
| aflatoxin B1 | affects expression | ISO | RGD:1605946 | 6480464 | Aflatoxin B1 affects the expression of E2F8 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1605946 | 6480464 | Aflatoxin B1 results in increased expression of E2F8 mRNA | CTD | PMID:22100608 |
| arsenic atom | decreases expression | ISO | RGD:1605946 | 6480464 | Arsenic results in decreased expression of E2F8 mRNA | CTD | PMID:19945496 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1605946 | 6480464 | Benzo(a)pyrene results in decreased expression of E2F8 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1605946 | 6480464 | Benzo(a)pyrene results in decreased expression of E2F8 mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1605946 | 6480464 | Benzo(a)pyrene results in decreased expression of E2F8 mRNA | CTD | PMID:20064835 PMID:22316170 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of E2F8 mRNA | CTD | PMID:19770486 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of E2F8 mRNA | CTD | PMID:21932408 |
| calcitriol | decreases expression | ISO | RGD:1605946 | 6480464 | Calcitriol results in decreased expression of E2F8 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1605946 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of E2F8 mRNA | CTD | PMID:21592394 |
| cefaloridine | increases expression | ISO | RGD:1308091 | 6480464 | Cephaloridine results in increased expression of E2F8 mRNA | CTD | PMID:18500788 |
| copper atom | multiple interactions | ISO | RGD:1605946 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of E2F8 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1605946 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of E2F8 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1605946 | 6480464 | Copper Sulfate results in decreased expression of E2F8 mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1605946 | 6480464 | Coumestrol results in increased expression of E2F8 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1605946 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA; more ... | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1605946 | 6480464 | Cyclosporine results in decreased expression of E2F8 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1605946 | 6480464 | Cyclosporine results in decreased expression of E2F8 mRNA | CTD | PMID:20106945 PMID:21632981 |
| dibutyl phthalate | decreases expression | ISO | RGD:1308091 | 6480464 | Dibutyl Phthalate results in decreased expression of E2F8 mRNA | CTD | PMID:21266533 |
| iron atom | increases expression | ISO | RGD:1605946 | 6480464 | Iron deficiency results in increased expression of E2F8 mRNA | CTD | PMID:20368581 |
| isotretinoin | decreases expression | ISO | RGD:1605946 | 6480464 | Isotretinoin results in decreased expression of E2F8 mRNA | CTD | PMID:20436886 |
| kojic acid | increases expression | ISO | RGD:1605946 | 6480464 | kojic acid results in increased expression of E2F8 mRNA | CTD | PMID:16595896 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of E2F8 mRNA | CTD | PMID:18301758 |
| quinolin-8-ol | decreases expression | ISO | RGD:1605946 | 6480464 | Oxyquinoline results in decreased expression of E2F8 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1605946 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA | CTD | PMID:19167446 |
| sodium dichromate | affects expression | ISO | RGD:1308091 | 6480464 | sodium bichromate affects the expression of E2F8 mRNA | CTD | PMID:22110744 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F8 mRNA | CTD | PMID:21641980 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of E2F8 mRNA | CTD | PMID:17555576 |
| testosterone | multiple interactions | ISO | RGD:1605946 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of E2F8 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1605946 | 6480464 | Testosterone results in decreased expression of E2F8 mRNA | CTD | PMID:21592394 |
| thioacetamide | increases expression | ISO | RGD:1308091 | 6480464 | Thioacetamide results in increased expression of E2F8 mRNA | CTD | PMID:22659510 |
| trans-resveratrol | multiple interactions | ISO | RGD:1605946 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of E2F8 mRNA | CTD | PMID:19042947 |
| tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of E2F8 mRNA | CTD | PMID:17127020 |